Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TXG compared with ARCT: revenue, margins and what each company keeps, and the suppliers and customers both name
TXG
10x Genomics, Inc.
Change
Mkt cap
Revenue
Revenue
ARCT
Arcturus Therapeutics Holdings Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
TXG
10x Genomics, Inc.
vs
ARCT
Arcturus Therapeutics Holdings Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TXG, solid
ARCT, dashed
TXG
10x Genomics, Inc.
Change
59.06
▲
+1.72%
· post 59.44
Mkt cap
$7.8B
Revenue
$151M
Q3 FY26
Revenue
$643M
FY25
ARCT
Arcturus Therapeutics Holdings Inc.
Change
10.36
▲
+10.67%
· post 10.36
Closed
Nov 6 '26
Mkt cap
$298.3M
Revenue
$18M
Q3 FY26
Revenue
$82M
FY25
vs
Compare
Closed
Nov 6 '26
TXG
10x Genomics, Inc.
vs
ARCT
Arcturus Therapeutics Holdings Inc.
59.06
▲
+1.72%
post 59.44
Price
10.36
▲
+10.67%
post 10.36
$7.8B
Mkt cap
$298.3M
Q3 FY26
$151M
Revenue
$18M
Q3 FY26
FY25
$643M
Revenue
$82M
FY25
Change
Change
TXG
59.06
▲
+1.72%
vs
ARCT
10.36
▲
+10.67%
Closed
Nov 6 '26